XML 51 R40.htm IDEA: XBRL DOCUMENT v3.25.1
Collaborative Arrangements - Bayer AG (Details) - USD ($)
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Sales $ 15,529,000,000 $ 15,775,000,000  
Cost of sales 3,419,000,000 3,540,000,000  
Selling, general and administrative 2,552,000,000 2,483,000,000  
Research and development 3,621,000,000 3,992,000,000  
Other current assets 35,503,000,000   $ 38,782,000,000
Accrued and other current liabilities 12,772,000,000   15,694,000,000
Bayer AG | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Eligible future contingent sales-based milestone payments (up to) 0    
Revenue from collaborative arrangement 106,000,000 98,000,000  
Sales 183,000,000 173,000,000  
Cost of sales 58,000,000 62,000,000  
Selling, general and administrative 29,000,000 33,000,000  
Research and development 24,000,000 28,000,000  
Other current assets 160,000,000   160,000,000
Accrued and other current liabilities 83,000,000   $ 82,000,000
Adempas | Bayer AG | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Sales 68,000,000 70,000,000  
Adempas | Licenses and Other      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Finite-lived intangible assets 353,000,000    
Verquvo | Bayer AG | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Sales 9,000,000 $ 5,000,000  
Verquvo | Licenses and Other      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Finite-lived intangible assets $ 42,000,000